Get started
Iovance Biotherapeutics, Inc.
Long

IOVA - good long term hold

128
IOVA has FDA fast track approval for new cancer immune therapy drug
rollingw
Trend Analysis

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.
Trend Analysis
rollingw

Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.